Affordable Access

Publisher Website

P16 gene deletions and point mutations in patients with agnogenic myeloid metaplasia (AMM)

Authors
Journal
Leukemia Research
0145-2126
Publisher
Elsevier
Publication Date
Volume
23
Issue
7
Identifiers
DOI: 10.1016/s0145-2126(99)00080-6
Keywords
  • P16 Gene
  • Agnogenic Myeloid Metaplasia
  • Myelofibrosis
Disciplines
  • Medicine

Abstract

Abstract Studies of p16 alterations with homozygous deletions and mutation analysis were done in 32 patients with agnogenic myeloid metaplasia (AMM) including six patients in leukemic phase. No homozygous deletions were found and, one patient was found to have a shift band in exon 2C fragment by PCR-SSCP analysis. Further sequence analysis demonstrated that the mutated band was a point mutation of G to A in exon 2 codon 140 (GCG→ACG) causing an amino acid substitution of alanine to threonine demonstrating this patient either carried an mutated gene in one allele as a polymorphism (heterozygous carrier of a mutant p16 gene) or carried a mutant p16 gene clone. This study demonstrates that p16 alterations with homozygous deletions and mutations were very rare in patients with AMM. A single patient found to have a shifted band by PCR-SSCP may be represented as a coincidence or as a polymorphism with a heterozygous carrier of mutated p16 gene, predisposable to AMM or as a mutant p16 gene which can be infrequently observed in this disease.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Hypermethylation of the P15INK4b and P16INK4a in a...

on British Journal of Haematology March 2002

Deletions and point mutations of p16,p15 gene in p...

on Chinese Medical Sciences Journ... December 1999

[p16INK4/CDKN2 gene deletions and mutations in non...

on Zhonghua yi xue yi chuan xue z... Feb 10, 1998
More articles like this..